Наркомания. Нейропептид Морфиновые рецепторы - Зайцев С.В.
ISBN 5-211-02349-8
Скачать (прямая ссылка):
Vickroy T.W., Yamamura H.I., Roeske W.R. Differential regulation of high affinity agonist binding to muscarinic sites in the rat heart, cerebellum, and cerebral cortex // Biochem. Biophys. Res. Communs. 1983. V. 116. N 1. P. 284-290.
Victor М., Brausch C. The role of abstinence in the genesis of alcohol epilepsy // Epilepsia. 1967. V. 8. N 1. P. 1-20.
Vignon J., Chickeportiche R., Ckickeportiche M. et al. [3H]TCP: A new tool with high affinity for the PCP receptor in rat brain // Brain Res. 1983. V. 280. N 1. P. 194-197.
Vinayek R., Brown D.R., Miller R.J. Inhibition of the antisecretorj effects of [D-Ala2, D-Leu5]-enkephalin in the guinea pig ileum by selective delta opioid antagonist // Europ. J. Pharmacol. 1983. V. 91. N 1-2. P. 159-161.
Wamsley J.K. Opioid receptors: autoradiography // Pharm. Rev. 1983. V. 35. N 1. P. 69-83.
Ward S.J., LoPresti D., James D.W. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: differentiation into peptide and nonpeptide classes with beta-funaltrexamine // .1. Pharmacol. Exp. Ther. 1986. V. 238. N 2. P. 625-631.
Way E.L., Loh H.H., Shen F.H. Morphine tolerance, physical dependence and synthesis of brain 5-hydroxytryptamine // Science. 1968. V. 162. P. 1290-1292.
Weiss E.R., Kelleher J., Woon C. W. et al. Receptor activation of G-proteins // FASEB J. 1988. V. 2. P. 2841-2849.
Werling L.L., McMahon P.N., Cox B.M. Selective changes in ц opioid receptor properties induced by chronic morphine exposure j j Proc. Natl. Acad. Sci. USA. 1989. V. 86. P. 6393-6397.
Wesshng-Resnich М., Kelleher D.J., Weiss E.R. et al. Enzymatic model for receptor activation of GTP-binding regulatory proteins // Trends in Biochem. Sci. 1987. V. 12. P. 473-477.
Westphal М., Li C.H. Beta-endorphin: demonstration of binding sites in the three human neuroblastoma cell lines specific for the COO II-terminal segment of the human hormone // Biochem. Biophys. Res. Comm. 1984. P. 873-878.
Westphal М., Li C.H. /2-Endorphin: characterization of binding sites specific for the human hormone in human glioblastoma SF 126 cells // Proc. Natl. Acad. Sci. USA. 1984. V. 81. N 9. P. 2921-2923.
Widdowson P.S. The effect of neurotensin, TRH, a the 6-opioid receptor antagonist ICI 174864 on alcohol-induced narcosis in rats // Brain Res. 1987. V. 424. N 2. P. 281-289.
Wikler A. Opioid dependence: Mechanisms and treatment. Plenum Press. N. Y.; L., 1980. 255 p.
Williams N., Clonet D.H. // J. Pharmacol. Exp. Ther. 1982. V. 220. N 2. P. 278.
Wilson K.M., Minneman K.P. Regional variations in oi-adrenergic receptor subtypes in rat brain j j J. Neurochem. 1989. V. 53. P. 1782-1786.
Wolfe S.A., Jr., Kulsakdinun C., Battaglia G. et al. Initial identification and characterization J. Pharmacol. Exp. Ther. 1988. V. 247. N 3. P. 1114-1119.
Wolozin B.L.. Pasternak G.W. Classification of multiple morphine and enkephalin binding sites in the central nervous system // Proc. Natl. Acad. Sci. USA. 1981. V. 78. N 10. P. 6181-6185.
Wood L.A. Distribution and fate of morphine in non-tolerant and tolerant dogs ard rats // J. Pharmacol. Exp. Ther. 1954. V. 112. N 2. P. 158-175.
Wood P L . Pilapd С. H. Kappa-opiate receptor sites: unigue heat stability in vitrc // Europ. j. Pharmacol. 1983. V. 88. N 2-3. P. 281-282.
Wuster М., Schultz R., Herz A. The direction of opioid agonists toward* fi-, <5- and x-re-’eptors in the vas deferens of the mouse and the rai
11 Life Sci. 1980. V. 27. N 2. P. 163-170.
Wybran J. Enkephalins and endorphins as modifiers of immune system: present and future j j Fed. Proc. 1985. V. 44. N 2. P. 92-94.
Wybran J., Appelboom Т., Famaey J.-P. et al. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes // J. Immunol. 1979. V. 123. N 3. P. 1068-1070.
Wybran J., Appelboom Т., Famaey J.-P. et al. Receptors for morphine and methionine-enkephalin on human T-lymphocytes: the two hits opioid lymphocyte receptor hypothesis // New Trands Human Immunol. Cancer Immunother. (Proc.). Paris, 1980.
Yamamoto I., Inski R., Tamari Y. et al. Inhibitory effect of 8-azaguanine on the development of tolerance in the analgesic action of morphine // Jap. J. Pharmacol. 1967. V. 17. P. 140-142.
Yatani A., Imoto Y., Codin a J. et al. The stimulatory G protein of adenylyl cyclase Gs also stimulates dihydropyridine - sensitive Ca2+ channels // J. Biol. Chem. 1988. V. 263. P. 9887-9895.
Yarygin K.N. The interactions of opioids with entrocyte membranes: Evidence for enzyme-catalyzed covalent binding // Collect. Czech. Chem. Commun. 1990. V. 55. P. 2328-2338.
Young G.A., Khazan N. Differential tolerance and cross-tolerance to repeated daily injections of mu and kappa opioid agonists in the rat // Neuropharmacology. 1984. V. 23. N 5. P. 505-509.
Yu V.C., Sadee W. Phosphatidylmosital turnover in neuroblastoma cells: regulation by bradykinin, acetylcholine but not Ц- and 6-opioid receptors // Neurosci. Lett. 1986. V. 71. P. 219.
Zagon I.S., McLaughin P.J. Endogenous opioid systems regulate growth of neural tumor cells in culture // Brain Res. 1989. V. 490. P. 14-25.
